What Did EPCAT III Find? – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”What did EPCAT III find?
In more than 5300 patients undergoing total hip or knee arthroplasty, symptomatic proximal DVT or pulmonary embolism occurred in:
- 0.48 percent of patients receiving aspirin alone
- 0.45 of patients receiving rivaroxaban for 5 days followed by aspirin
Aspirin alone met the trial’s prespecified criterion for noninferiority.
The findings provide important new evidence supporting aspirin alone as a thromboprophylaxis option after hip or knee arthroplasty in appropriately selected patients.
Patient selection remains important. Most participants in EPCAT III were classified as standard VTE risk, and patients with previous VTE or metastatic cancer were excluded.
In the latest CLOT Conversations, lead author Dr. Sudeep Shivakumar discusses the results with Dr.Jameel Abdulrehman and what they may mean for clinical practice.
More posts about Thrombosis CanadaThrombosis Canada on Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target